中文
Executive Team
Jasmine Cui Ph.D.
Co-Founder Chairwoman and CEO
Founder’s Message
We founded InnoCare with the mission of saving and empowering lives by enabling patient’s access to the finest innovative drugs. As visionaries and trailblazers in the biopharmaceutical sector, we uphold the philosophy of ‘Science Drives Innovation for the Benefit of Patients’, dedicating ourselves to creating innovative drugs for cancer and autoimmune diseases. Recognizing that talent is the bedrock of biopharmaceutical innovation, InnoCare has always put talent at the top of its corporate development agenda. With a high-caliber talent team and top-tier innovation capabilities, we believe that InnoCare is well on track to become a world-class pharmaceutical company. 
— Jasmine Cui Ph.D.
Xiangyang Chen Ph.D.
CTO
Sean Zhang MD
CMO
Kevin Gao Ph.D.
COO
Mr. Xin Fu
CFO
Mr. Jeff Chen
CCO
Richard Liu Ph.D.
Vice President of Biology and Procurement
Charles Y. Wang Ph.D., DABT
Vice President of Drug Safety & DMPK
Renbin Zhao Ph.D.
Vice President of Clinical Development and Medical Research
Norman Kong Ph.D.
Vice President of Medicinal Chemistry
Boyan Zhang Ph.D.
Vice President of Biologics CMC
Manish Tandon Ph.D.
Vice President of Business Development
Carrie Zhou Ph.D.
Vice President of Medical Research
Jessie Wang
General Counsel
Scientific Advisory Board
Yigong Shi Ph.D.
InnoCare Co-founder & President of SAB
Founder’s Message
As China emerges as a formidable biopharmaceutical force, we've advanced in our capabilities, moving from producing best-in-class drugs to pioneering first-in-class medicines. We hope to independently develop more innovative drugs. Our innovation is fueled by an unwavering vision to improve human well-being, a goal which through our collective efforts is gradually becoming a reality.
— Yigong Shi Ph.D.
Zemin Zhang Ph.D.
Member of SAB
Zhanguo Li Ph.D.
Member of SAB
Arnold J. Levine Ph.D.
Member of SAB
James Deng
Sales & Marketing Advisor
